The Atlantic Pediatric Device Consortium provides a national platform to translate ideas through the product development pathway all the way to commercialization.  With funding from the FDA Office of Orphan Products Development, our mission is to enhance the lives of children through the development of novel pediatric medical devices which are both safe and effective.  The Consortium fosters an environment of creativity, where innovative ideas are reviewed, tested, and developed by a multidisciplinary team of experts from the Georgia Institute of Technology, Emory University, and Children’s Healthcare of Atlanta.  With its roots firmly established in the Atlanta engineering and medical communities, in 2013 APDC was awarded renewal funding from the FDA and has expanded its geographical footprint along the east coast to include the Virginia Commonwealth University


What's New
Atlanta-based consortium on leading edge of pediatric device development.
GCMI and APDC partnering on MedTech Innovation Series 2014
Round 1 winners will present their pediatric device projects to a panel of expert reviewers who will provide feedback and final evaluation.
This cleft palate implant uses a strong hydrogel plus an asymmetric design that can resist pressure but also allow for growth of the child’s mouth.
The SealCath double balloon catheter is designed solely for the treatment of intussusception, a life-threatening illness that occurs in children.
The Norwood Procedure is the first in a series of palliative surgical procedures to treat Hypoplastic Left Heart Syndrome (HLHS), one of the most complex congenital heart defects.